Found 6 matching trials
Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001) PHASE1 This study will evaluate the safety, tolerability, and immunogenicity of va...
Show More Location
Multiple Locations
Learn More & Join Trial
V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002) PHASE2 This study evaluated the safety, tolerability, and efficacy of the cytomega...
Show More Location
Alabama Clinical Therapeutics ( Site 0025)
Learn More & Join Trial
Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients PHASE3 This study aims to compare and assess the efficacy and the safety of the co...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension PHASE2 The purpose of this study is to evaluate the safety and efficacy of fixed c...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension. PHASE4 The purpose of the study is to evaluate the safety and efficacy of initial ...
Show More Location
Investigative site
Learn More & Join Trial
Safety and Immunogenicity of the Human Cytomegalovirus (CMV) Vaccine (V160) in Healthy Japanese Men (V160-003) PHASE1 The purpose of the study is to assess the safety and tolerability of a 3-do...
Show More Location
Souseikai PS Clinic ( Site 0001)
Learn More & Join Trial